Evidence map›Paper›PMID 28143939›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist.

Jesung Moon, Huanyu Zhou, Li-Shu Zhang, Wei Tan, Ying Liu, Shanrong Zhang, Lorraine K Morlock, Xiaoping Bao, Sean P Palecek, Jian Q Feng and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Signaling pathways and targeted therapy for myocardial infarction.Signal transduction and targeted therapy · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Cardiac fibrosis.Cardiovascular research · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Jesung MoonDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Huanyu ZhouDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Li-Shu ZhangHamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Wei TanDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Ying LiuDepartment of Biomedical Sciences, Texas A&M University College of Dentistry, Dallas, TX 75246.
Shanrong ZhangAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Lorraine K MorlockDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Xiaoping BaoDepartment of Chemical and Biological Engineering, University of Wisconsin Madison, Madison, WI 53706.
Sean P PalecekDepartment of Chemical and Biological Engineering, University of Wisconsin Madison, Madison, WI 53706.
Jian Q FengDepartment of Biomedical Sciences, Texas A&M University College of Dentistry, Dallas, TX 75246.
Noelle S WilliamsDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390.
James F AmatrudaDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Eric N OlsonDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390; Eric.Olson@utsouthwestern.edu lawrence.lum@utsouthwestern.edu.
Rhonda Bassel-DubyDepartment of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390.
Lawrence LumHamon Center for Regenerative Science and Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390; Eric.Olson@utsouthwestern.edu lawrence.lum@utsouthwestern.edu.
The University of Texas Southwestern Medical Center · USUniversity of Wisconsin–Madison · US

Funding

Microenvironmental control of progenitors in organ dysfunction and repairU01HL100401 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI OLSON, ERIC N, SCHNEIDER, JAY W · 2009 to 2015
$8.3M
Heart Repair through Reprogramming of Cardiac Cell FateR01HL077439 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI OLSON, ERIC N · 2004 to 2015
$6.2M
Deciphering the role of a novel micropeptide in cardiac function and dysfunctionR01HL130253 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI BASSEL-DUBY, RHONDA, OLSON, ERIC N · 2016 to 2023
$4.4M
Regulating human pluripotent stem cell differentiation by colony confinementR01EB007534 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2007 to 2019
$4.1M
Chemical disruption of Wnt-mediated signal transductionR01CA168761 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI KIM, JAMES · 2013 to 2017
$2.3M
Metabolic Control by Myogenic MicroRNAs, Mediator and MyokinesR01DK099653 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI BASSEL-DUBY, RHONDA, OLSON, ERIC N · 2013 to 2016
$1.9M
Molecular Dissection of Myoblast Fusion In Muscle Development and RegenerationR01AR067294 · NIAMS · UT SOUTHWESTERN MEDICAL CENTER · PI BASSEL-DUBY, RHONDA, OLSON, ERIC N · 2015 to 2019
$1.8M
Rodent Ultrasound Imaging SystemS10RR023729 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI HILL, JOSEPH A · 2009 to 2009
$290k
NCI NIH HHS R01 CA168761NCRR NIH HHS S10 RR023729NHLBI NIH HHS R01 HL077439NHLBI NIH HHS R01 HL130253NHLBI NIH HHS U01 HL100401NIAMS NIH HHS R01 AR067294NIBIB NIH HHS R01 EB007534NIDDK NIH HHS R01 DK099653
6 · The paper itself

Abstract

The secreted Wnt signaling molecules are essential to the coordination of cell-fate decision making in multicellular organisms. In adult animals, the secreted Wnt proteins are critical for tissue regeneration and frequently contribute to cancer. Small molecules that disable the Wnt acyltransferase Porcupine (Porcn) are candidate anticancer agents in clinical testing. Here we have systematically assessed the effects of the Porcn inhibitor (WNT-974) on the regeneration of several tissue types to identify potentially unwanted chemical effects that could limit the therapeutic utility of such agents. An unanticipated observation from these studies is proregenerative responses in heart muscle induced by systemic chemical suppression of Wnt signaling. Using in vitro cultures of several cell types found in the heart, we delineate the Wnt signaling apparatus supporting an antiregenerative transcriptional program that includes a subunit of the nonfibrillar collagen VI. Similar to observations seen in animals exposed to WNT-974, deletion of the collagen VI subunit,

Indexed as

AcyltransferasesAnimalsAtrial RemodelingCells, CulturedCollagen Type VIEnzyme InhibitorsGene ExpressionHEK293 CellsHumansMembrane ProteinsMice, Inbred C57BLMolecular StructureMyocardial InfarctionPyrazinesPyridinesRegenerationAcyltransferasesCollagen Type VIEnzyme InhibitorsLGK974Membrane ProteinsPorcn protein, mousePyrazinesPyridinesadult tissue homeostasisextracellular matrixheart regenerationprotein lipidationWnt

Identifiers

PMID28143939
PMCPMC5320972
OpenAlexW2583608393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.